Menu

Coya Therapeutics, Inc. COYA

Full chart Compare
Set alert

Price alert · COYA

All alert types
3.21 USD +0.05 (+1.58%)

At closeNov 11, 2026, 4:55 PM EST

3.09 -0.12 -3.73%

After hours · Nov 11, 4:55 PM ET

3.17 Day range 3.31
2.72 52-week range 6.62
YTD
-44.66%
1 year
-46.59%

Revenue & Expenses

Revenue → Gross Profit: $7.92MGross Profit → Expenses: $7.92MRevenue → Cost of Revenue: $27.36KExpenses → Selling, General & Admin: $11.45MExpenses → Research & Development: $16.73MExpenses → Other Expenses: $957.39KExpenses → Income Tax: $3.09KNet Loss → Expenses: $21.23MGross Profit$7.92MNet Loss$21.23MCost of Revenue$27.36KExpenses$29.14MSelling, General & Admin$11.45MResearch & Development$16.73MOther Expenses$957.39KIncome Tax$3.09KRevenue$7.95M

Latest period ending Dec 31, 2025 · select a line to chart its full history

COYA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
7.95M3.55M6.00M00
7.95M3.55M6.00M00
-22.56M-17.25M-7.90M-9.81M-4.87M
-21.23M-14.88M-7.99M-12.24M-4.89M
-1.27-0.98-0.79-4.73-1.89
COYA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
46.82M38.34M32.63M5.93M4.34M
49.95M44.35M41.26M8.40M4.79M
6.92M4.77M5.63M16.79M1.15M
43.03M39.58M35.64M-8.39M3.64M
COYA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-10.74M-10.29M-11.19M-7.24M-3.90M
-1.16M-25.00K-543.19K-525.00K-136.80K
20.39M16.03M38.43M9.36M-340.58K
8.48M5.71M26.69M1.59M-4.38M